| 666708 |
FRONTIERS IN ONCOLOGY |
Patient-Derived Cancer Organoids as Predictors of Treatment Response |
2021-03-18 |
10.3389/fonc.2021.641980 |
Verduin Maikel, Hoeben Ann, De Ruysscher Dirk, Vooijs Marc |
| 666707 |
FRONTIERS IN ONCOLOGY |
Risk for Invasive Cancers in Women With Breast Cancer In Situ: Results From a Population Not Covered by Organized Mammographic Screening |
2021-03-18 |
10.3389/fonc.2021.606747 |
Karavasiloglou Nena, Matthes Katarina L., Pestoni Giulia, Limam Manuela, Korol Dimitri, Wanner Miriam, Rohrmann Sabine |
| 666706 |
FRONTIERS IN ONCOLOGY |
COL5A2 Promotes Proliferation and Invasion in Prostate Cancer and Is One of Seven Gleason-Related Genes That Predict Recurrence-Free Survival |
2021-03-18 |
10.3389/fonc.2021.583083 |
Ren Xiaohan, Chen Xinglin, Fang Kai, Zhang Xu, Wei Xiyi, Zhang Tongtong, Li Guangyao, Lu Zhongwen, Song Ninghong, Wang Shangqian, Qin Chao |
| 666705 |
FRONTIERS IN ONCOLOGY |
Permanent Interstitial Cesium-131 Brachytherapy in Treating High-Risk Recurrent Head and Neck Cancer: A Prospective Pilot Study |
2021-03-18 |
10.3389/fonc.2021.639480 |
Kharouta Michael, Zender Chad, Podder Tarun, Rezaee Rod, Lavertu Pierre, Fowler Nicole, Thuener Jason, Li Shawn, Clancy Kate, Xu Zhengzheng, Yao Min |
| 666704 |
FRONTIERS IN ONCOLOGY |
Identification of a Six Gene Prognosis Signature for Papillary Thyroid Cancer Using Multi-Omics Methods and Bioinformatics Analysis |
2021-03-18 |
10.3389/fonc.2021.624421 |
Ren He, Liu Xin, Li Fuxin, He Xianghui, Zhao Na |
| 666703 |
FRONTIERS IN ONCOLOGY |
Impact of Postoperative Radiotherapy on Survival of Patients With de novo Stage IV Breast Cancer: A Population-Based Study From the SEER Database |
2021-03-18 |
10.3389/fonc.2021.625628 |
Zhang Jie, Luo Shiping, Qiu Zhaozhen, Lin Yuxiang, Song Chuangui |
| 666702 |
FRONTIERS IN ONCOLOGY |
Differences in Tumor Immune Microenvironment in Metastatic Sites of Breast Cancer |
2021-03-18 |
10.3389/fonc.2021.649004 |
Lee Hyunjong, Na Kwon Joong, Choi Hongyoon |
| 666701 |
FRONTIERS IN ONCOLOGY |
Correlation Between Dual-Time-Point FDG PET and Tumor Microenvironment Immune Types in Non-Small Cell Lung Cancer |
2021-03-18 |
10.3389/fonc.2021.559623 |
Zhou Jianyuan, Zou Sijuan, Cheng Siyuan, Kuang Dong, Li Dan, Chen Lixing, Liu Cong, Yan Jianhua, Zhu Xiaohua |
| 666700 |
FRONTIERS IN ONCOLOGY |
Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma |
2021-03-18 |
10.3389/fonc.2021.670714 |
Zhang Meng-Xia, Wang Li, Zeng Lei, Tu Zi-Wei |
| 666699 |
FRONTIERS IN ONCOLOGY |
Targeting the MDSCs of Tumors In Situ With Inhibitors of the MAPK Signaling Pathway to Promote Tumor Regression |
2021-03-18 |
10.3389/fonc.2021.647312 |
Yu Jiayun, Li Hanwen, Zhang Zongliang, Lin Weimin, Wei Xiawei, Shao Bin |
